This is an Application Brief and does not contain a detailed Experimental section.
This application brief demonstrates analysis of verapamil.
The compound analyzed in this study is verapamil.
USP Tailing Factor
Column: |
Symmetry C8, 3.9 x 150 mm, 5 μm |
Guard Column: |
Sentry Guard Column 3.9 x 20mm, 5 μm |
Part numbers: |
Column - WAT046970, Guard - WAT054250 |
Mobile phase: |
10 mM sodium acetate with 3.3% glacial acetic acid, pH 2.6/acetonitrile 70:30 |
Flow rate: |
1.0 mL/min |
Injection volume: |
10 μL of 100 μg/mL sample |
Detection: |
UV @ 278 nm |
WA31763.177, June 2003